RT @LivUniLRiG: We've been quiet recently but only because we've been busily beavering away in our little LRiG dam to get a paper published…
We've been quiet recently but only because we've been busily beavering away in our little LRiG dam to get a paper published with @PECjournal. https://t.co/ZKMj25OYEY #medicaltreatments #chemotherapy #technologyappraisal #NICE
#HealthEconJA Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal https://t.co/WpgZlUMQex
RT @LivUniLRiG: Here is the latest publication from the team, Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One…
Here is the latest publication from the team, Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. https://t.co/N3rOoIH7Sa
New #Pharmacoeconomic open article with my @LivUniLRiG colleagues. "Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal" https://t.